nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2C19—prostate cancer	0.185	0.611	CbGaD
Bupivacaine—CYP3A4—prostate cancer	0.118	0.389	CbGaD
Bupivacaine—CYP2C19—Bicalutamide—prostate cancer	0.0365	0.086	CbGbCtD
Bupivacaine—CYP2C19—Nilutamide—prostate cancer	0.0365	0.086	CbGbCtD
Bupivacaine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0336	0.0792	CbGbCtD
Bupivacaine—CYP2C19—Flutamide—prostate cancer	0.0302	0.0713	CbGbCtD
Bupivacaine—CYP1A2—Flutamide—prostate cancer	0.0279	0.0658	CbGbCtD
Bupivacaine—CYP2D6—Bicalutamide—prostate cancer	0.0277	0.0654	CbGbCtD
Bupivacaine—CYP2D6—Abiraterone—prostate cancer	0.023	0.0542	CbGbCtD
Bupivacaine—CYP1A2—Estrone—prostate cancer	0.0202	0.0475	CbGbCtD
Bupivacaine—CYP3A4—Bicalutamide—prostate cancer	0.0176	0.0416	CbGbCtD
Bupivacaine—CYP3A4—Estramustine—prostate cancer	0.0164	0.0387	CbGbCtD
Bupivacaine—CYP3A4—Abiraterone—prostate cancer	0.0146	0.0345	CbGbCtD
Bupivacaine—CYP3A4—Flutamide—prostate cancer	0.0146	0.0345	CbGbCtD
Bupivacaine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0132	0.0311	CbGbCtD
Bupivacaine—CYP2C19—Estradiol—prostate cancer	0.0125	0.0296	CbGbCtD
Bupivacaine—CYP1A2—Estradiol—prostate cancer	0.0116	0.0273	CbGbCtD
Bupivacaine—CYP3A4—Cabazitaxel—prostate cancer	0.0108	0.0255	CbGbCtD
Bupivacaine—CYP2C19—Prednisone—prostate cancer	0.0108	0.0255	CbGbCtD
Bupivacaine—CYP3A4—Estrone—prostate cancer	0.0106	0.0249	CbGbCtD
Bupivacaine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00941	0.0222	CbGbCtD
Bupivacaine—CYP1A2—Etoposide—prostate cancer	0.00756	0.0178	CbGbCtD
Bupivacaine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00691	0.0163	CbGbCtD
Bupivacaine—CYP3A4—Mitoxantrone—prostate cancer	0.00628	0.0148	CbGbCtD
Bupivacaine—CYP3A4—Estradiol—prostate cancer	0.00607	0.0143	CbGbCtD
Bupivacaine—CYP3A4—Prednisone—prostate cancer	0.00522	0.0123	CbGbCtD
Bupivacaine—CYP2D6—Doxorubicin—prostate cancer	0.00425	0.01	CbGbCtD
Bupivacaine—CYP3A4—Etoposide—prostate cancer	0.00396	0.00934	CbGbCtD
Bupivacaine—CYP3A4—Docetaxel—prostate cancer	0.00362	0.00855	CbGbCtD
Bupivacaine—CYP3A4—Doxorubicin—prostate cancer	0.0027	0.00637	CbGbCtD
Bupivacaine—CYP2C19—urine—prostate cancer	0.0021	0.163	CbGeAlD
Bupivacaine—PTGER1—renal system—prostate cancer	0.00181	0.14	CbGeAlD
Bupivacaine—CYP1A2—urine—prostate cancer	0.00172	0.133	CbGeAlD
Bupivacaine—SCN4A—prostate gland—prostate cancer	0.00151	0.117	CbGeAlD
Bupivacaine—CYP3A4—urine—prostate cancer	0.00124	0.0962	CbGeAlD
Bupivacaine—CYP2D6—urine—prostate cancer	0.00122	0.0946	CbGeAlD
Bupivacaine—SCN4A—renal system—prostate cancer	0.00103	0.0796	CbGeAlD
Bupivacaine—SCN4A—testis—prostate cancer	0.000665	0.0515	CbGeAlD
Bupivacaine—Lidocaine—CYP2C18—prostate cancer	0.00048	0.206	CrCbGaD
Bupivacaine—CYP1A2—renal system—prostate cancer	0.00042	0.0325	CbGeAlD
Bupivacaine—SCN10A—lymph node—prostate cancer	0.000411	0.0318	CbGeAlD
Bupivacaine—Lidocaine—EGFR—prostate cancer	0.000375	0.161	CrCbGaD
Bupivacaine—Lidocaine—CYP3A5—prostate cancer	0.000316	0.136	CrCbGaD
Bupivacaine—Lidocaine—CYP2A6—prostate cancer	0.000306	0.131	CrCbGaD
Bupivacaine—CYP3A4—renal system—prostate cancer	0.000304	0.0235	CbGeAlD
Bupivacaine—CYP2D6—renal system—prostate cancer	0.000299	0.0232	CbGeAlD
Bupivacaine—Levobupivacaine—CYP3A4—prostate cancer	0.000292	0.125	CrCbGaD
Bupivacaine—Ranolazine—CYP3A4—prostate cancer	0.000238	0.102	CrCbGaD
Bupivacaine—CYP2D6—testis—prostate cancer	0.000193	0.015	CbGeAlD
Bupivacaine—Ropivacaine—CYP3A4—prostate cancer	0.000188	0.0807	CrCbGaD
Bupivacaine—Lidocaine—CYP3A4—prostate cancer	0.000137	0.0587	CrCbGaD
Bupivacaine—Anxiety—Capecitabine—prostate cancer	4.98e-05	0.000301	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.96e-05	0.0003	CcSEcCtD
Bupivacaine—Anaphylactic shock—Docetaxel—prostate cancer	4.95e-05	0.000299	CcSEcCtD
Bupivacaine—Oedema—Docetaxel—prostate cancer	4.95e-05	0.000299	CcSEcCtD
Bupivacaine—Vision blurred—Prednisone—prostate cancer	4.93e-05	0.000298	CcSEcCtD
Bupivacaine—Infection—Docetaxel—prostate cancer	4.92e-05	0.000297	CcSEcCtD
Bupivacaine—Feeling abnormal—Etoposide—prostate cancer	4.91e-05	0.000297	CcSEcCtD
Bupivacaine—Diarrhoea—Mitoxantrone—prostate cancer	4.9e-05	0.000296	CcSEcCtD
Bupivacaine—Vomiting—Estradiol—prostate cancer	4.88e-05	0.000296	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Etoposide—prostate cancer	4.87e-05	0.000295	CcSEcCtD
Bupivacaine—Shock—Docetaxel—prostate cancer	4.87e-05	0.000295	CcSEcCtD
Bupivacaine—Nervous system disorder—Docetaxel—prostate cancer	4.85e-05	0.000294	CcSEcCtD
Bupivacaine—Infestation NOS—Doxorubicin—prostate cancer	4.84e-05	0.000293	CcSEcCtD
Bupivacaine—Drowsiness—Doxorubicin—prostate cancer	4.84e-05	0.000293	CcSEcCtD
Bupivacaine—Infestation—Doxorubicin—prostate cancer	4.84e-05	0.000293	CcSEcCtD
Bupivacaine—Anaemia—Prednisone—prostate cancer	4.83e-05	0.000292	CcSEcCtD
Bupivacaine—Confusional state—Capecitabine—prostate cancer	4.83e-05	0.000292	CcSEcCtD
Bupivacaine—Tachycardia—Docetaxel—prostate cancer	4.83e-05	0.000292	CcSEcCtD
Bupivacaine—Headache—Estradiol—prostate cancer	4.81e-05	0.000291	CcSEcCtD
Bupivacaine—Skin disorder—Docetaxel—prostate cancer	4.81e-05	0.000291	CcSEcCtD
Bupivacaine—Agitation—Prednisone—prostate cancer	4.8e-05	0.000291	CcSEcCtD
Bupivacaine—Oedema—Capecitabine—prostate cancer	4.79e-05	0.00029	CcSEcCtD
Bupivacaine—Bradycardia—Epirubicin—prostate cancer	4.78e-05	0.000289	CcSEcCtD
Bupivacaine—Angioedema—Prednisone—prostate cancer	4.78e-05	0.000289	CcSEcCtD
Bupivacaine—Infection—Capecitabine—prostate cancer	4.76e-05	0.000288	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Doxorubicin—prostate cancer	4.75e-05	0.000287	CcSEcCtD
Bupivacaine—Urticaria—Etoposide—prostate cancer	4.73e-05	0.000286	CcSEcCtD
Bupivacaine—Shock—Capecitabine—prostate cancer	4.71e-05	0.000285	CcSEcCtD
Bupivacaine—Abdominal pain—Etoposide—prostate cancer	4.71e-05	0.000285	CcSEcCtD
Bupivacaine—Body temperature increased—Etoposide—prostate cancer	4.71e-05	0.000285	CcSEcCtD
Bupivacaine—Urinary tract infection—Doxorubicin—prostate cancer	4.71e-05	0.000285	CcSEcCtD
Bupivacaine—Nervous system disorder—Capecitabine—prostate cancer	4.7e-05	0.000284	CcSEcCtD
Bupivacaine—Syncope—Prednisone—prostate cancer	4.69e-05	0.000284	CcSEcCtD
Bupivacaine—Tachycardia—Capecitabine—prostate cancer	4.68e-05	0.000283	CcSEcCtD
Bupivacaine—Hypoaesthesia—Epirubicin—prostate cancer	4.67e-05	0.000283	CcSEcCtD
Bupivacaine—Skin disorder—Capecitabine—prostate cancer	4.65e-05	0.000282	CcSEcCtD
Bupivacaine—Sweating—Doxorubicin—prostate cancer	4.64e-05	0.000281	CcSEcCtD
Bupivacaine—Hyperhidrosis—Capecitabine—prostate cancer	4.63e-05	0.00028	CcSEcCtD
Bupivacaine—Oedema peripheral—Epirubicin—prostate cancer	4.63e-05	0.00028	CcSEcCtD
Bupivacaine—Hypotension—Docetaxel—prostate cancer	4.62e-05	0.00028	CcSEcCtD
Bupivacaine—Haematuria—Doxorubicin—prostate cancer	4.62e-05	0.000279	CcSEcCtD
Bupivacaine—Loss of consciousness—Prednisone—prostate cancer	4.6e-05	0.000278	CcSEcCtD
Bupivacaine—Nausea—Estradiol—prostate cancer	4.56e-05	0.000276	CcSEcCtD
Bupivacaine—Vomiting—Mitoxantrone—prostate cancer	4.55e-05	0.000275	CcSEcCtD
Bupivacaine—Convulsion—Prednisone—prostate cancer	4.53e-05	0.000274	CcSEcCtD
Bupivacaine—Hypertension—Prednisone—prostate cancer	4.51e-05	0.000273	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.51e-05	0.000273	CcSEcCtD
Bupivacaine—Headache—Mitoxantrone—prostate cancer	4.48e-05	0.000271	CcSEcCtD
Bupivacaine—Hypotension—Capecitabine—prostate cancer	4.48e-05	0.000271	CcSEcCtD
Bupivacaine—Insomnia—Docetaxel—prostate cancer	4.48e-05	0.000271	CcSEcCtD
Bupivacaine—Arthralgia—Prednisone—prostate cancer	4.45e-05	0.000269	CcSEcCtD
Bupivacaine—Paraesthesia—Docetaxel—prostate cancer	4.44e-05	0.000269	CcSEcCtD
Bupivacaine—Anxiety—Prednisone—prostate cancer	4.44e-05	0.000268	CcSEcCtD
Bupivacaine—Bradycardia—Doxorubicin—prostate cancer	4.42e-05	0.000268	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.42e-05	0.000268	CcSEcCtD
Bupivacaine—Dyspnoea—Docetaxel—prostate cancer	4.41e-05	0.000267	CcSEcCtD
Bupivacaine—Somnolence—Docetaxel—prostate cancer	4.4e-05	0.000266	CcSEcCtD
Bupivacaine—Hypersensitivity—Etoposide—prostate cancer	4.39e-05	0.000265	CcSEcCtD
Bupivacaine—Tinnitus—Epirubicin—prostate cancer	4.38e-05	0.000265	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.36e-05	0.000264	CcSEcCtD
Bupivacaine—Cardiac disorder—Epirubicin—prostate cancer	4.36e-05	0.000264	CcSEcCtD
Bupivacaine—Flushing—Epirubicin—prostate cancer	4.36e-05	0.000264	CcSEcCtD
Bupivacaine—Dyspepsia—Docetaxel—prostate cancer	4.36e-05	0.000264	CcSEcCtD
Bupivacaine—Insomnia—Capecitabine—prostate cancer	4.33e-05	0.000262	CcSEcCtD
Bupivacaine—Hypoaesthesia—Doxorubicin—prostate cancer	4.32e-05	0.000262	CcSEcCtD
Bupivacaine—Paraesthesia—Capecitabine—prostate cancer	4.3e-05	0.00026	CcSEcCtD
Bupivacaine—Decreased appetite—Docetaxel—prostate cancer	4.3e-05	0.00026	CcSEcCtD
Bupivacaine—Oedema peripheral—Doxorubicin—prostate cancer	4.28e-05	0.000259	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Docetaxel—prostate cancer	4.27e-05	0.000259	CcSEcCtD
Bupivacaine—Asthenia—Etoposide—prostate cancer	4.27e-05	0.000258	CcSEcCtD
Bupivacaine—Dyspnoea—Capecitabine—prostate cancer	4.27e-05	0.000258	CcSEcCtD
Bupivacaine—Anaphylactic shock—Prednisone—prostate cancer	4.27e-05	0.000258	CcSEcCtD
Bupivacaine—Oedema—Prednisone—prostate cancer	4.27e-05	0.000258	CcSEcCtD
Bupivacaine—Nausea—Mitoxantrone—prostate cancer	4.25e-05	0.000257	CcSEcCtD
Bupivacaine—Infection—Prednisone—prostate cancer	4.24e-05	0.000257	CcSEcCtD
Bupivacaine—Constipation—Docetaxel—prostate cancer	4.23e-05	0.000256	CcSEcCtD
Bupivacaine—Pain—Docetaxel—prostate cancer	4.23e-05	0.000256	CcSEcCtD
Bupivacaine—Dyspepsia—Capecitabine—prostate cancer	4.22e-05	0.000255	CcSEcCtD
Bupivacaine—Chills—Epirubicin—prostate cancer	4.21e-05	0.000255	CcSEcCtD
Bupivacaine—Pruritus—Etoposide—prostate cancer	4.21e-05	0.000255	CcSEcCtD
Bupivacaine—Shock—Prednisone—prostate cancer	4.2e-05	0.000254	CcSEcCtD
Bupivacaine—Arrhythmia—Epirubicin—prostate cancer	4.2e-05	0.000254	CcSEcCtD
Bupivacaine—Nervous system disorder—Prednisone—prostate cancer	4.18e-05	0.000253	CcSEcCtD
Bupivacaine—Tachycardia—Prednisone—prostate cancer	4.16e-05	0.000252	CcSEcCtD
Bupivacaine—Decreased appetite—Capecitabine—prostate cancer	4.16e-05	0.000252	CcSEcCtD
Bupivacaine—Skin disorder—Prednisone—prostate cancer	4.14e-05	0.000251	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Capecitabine—prostate cancer	4.14e-05	0.00025	CcSEcCtD
Bupivacaine—Hyperhidrosis—Prednisone—prostate cancer	4.13e-05	0.00025	CcSEcCtD
Bupivacaine—Mental disorder—Epirubicin—prostate cancer	4.12e-05	0.000249	CcSEcCtD
Bupivacaine—Constipation—Capecitabine—prostate cancer	4.1e-05	0.000248	CcSEcCtD
Bupivacaine—Pain—Capecitabine—prostate cancer	4.1e-05	0.000248	CcSEcCtD
Bupivacaine—Malnutrition—Epirubicin—prostate cancer	4.09e-05	0.000247	CcSEcCtD
Bupivacaine—Erythema—Epirubicin—prostate cancer	4.09e-05	0.000247	CcSEcCtD
Bupivacaine—Feeling abnormal—Docetaxel—prostate cancer	4.08e-05	0.000247	CcSEcCtD
Bupivacaine—Diarrhoea—Etoposide—prostate cancer	4.07e-05	0.000247	CcSEcCtD
Bupivacaine—Tinnitus—Doxorubicin—prostate cancer	4.05e-05	0.000245	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Docetaxel—prostate cancer	4.05e-05	0.000245	CcSEcCtD
Bupivacaine—Cardiac disorder—Doxorubicin—prostate cancer	4.03e-05	0.000244	CcSEcCtD
Bupivacaine—Flushing—Doxorubicin—prostate cancer	4.03e-05	0.000244	CcSEcCtD
Bupivacaine—Flatulence—Epirubicin—prostate cancer	4.03e-05	0.000244	CcSEcCtD
Bupivacaine—Tension—Epirubicin—prostate cancer	4.01e-05	0.000243	CcSEcCtD
Bupivacaine—Nervousness—Epirubicin—prostate cancer	3.97e-05	0.00024	CcSEcCtD
Bupivacaine—Back pain—Epirubicin—prostate cancer	3.96e-05	0.000239	CcSEcCtD
Bupivacaine—Feeling abnormal—Capecitabine—prostate cancer	3.95e-05	0.000239	CcSEcCtD
Bupivacaine—Dizziness—Etoposide—prostate cancer	3.94e-05	0.000238	CcSEcCtD
Bupivacaine—Muscle spasms—Epirubicin—prostate cancer	3.93e-05	0.000238	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Capecitabine—prostate cancer	3.92e-05	0.000237	CcSEcCtD
Bupivacaine—Body temperature increased—Docetaxel—prostate cancer	3.91e-05	0.000237	CcSEcCtD
Bupivacaine—Abdominal pain—Docetaxel—prostate cancer	3.91e-05	0.000237	CcSEcCtD
Bupivacaine—Chills—Doxorubicin—prostate cancer	3.9e-05	0.000236	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Prednisone—prostate cancer	3.89e-05	0.000235	CcSEcCtD
Bupivacaine—Arrhythmia—Doxorubicin—prostate cancer	3.88e-05	0.000235	CcSEcCtD
Bupivacaine—Insomnia—Prednisone—prostate cancer	3.86e-05	0.000234	CcSEcCtD
Bupivacaine—Vision blurred—Epirubicin—prostate cancer	3.85e-05	0.000233	CcSEcCtD
Bupivacaine—Paraesthesia—Prednisone—prostate cancer	3.83e-05	0.000232	CcSEcCtD
Bupivacaine—Mental disorder—Doxorubicin—prostate cancer	3.81e-05	0.00023	CcSEcCtD
Bupivacaine—Urticaria—Capecitabine—prostate cancer	3.81e-05	0.00023	CcSEcCtD
Bupivacaine—Abdominal pain—Capecitabine—prostate cancer	3.79e-05	0.000229	CcSEcCtD
Bupivacaine—Body temperature increased—Capecitabine—prostate cancer	3.79e-05	0.000229	CcSEcCtD
Bupivacaine—Vomiting—Etoposide—prostate cancer	3.79e-05	0.000229	CcSEcCtD
Bupivacaine—Malnutrition—Doxorubicin—prostate cancer	3.78e-05	0.000229	CcSEcCtD
Bupivacaine—Erythema—Doxorubicin—prostate cancer	3.78e-05	0.000229	CcSEcCtD
Bupivacaine—Anaemia—Epirubicin—prostate cancer	3.78e-05	0.000229	CcSEcCtD
Bupivacaine—Agitation—Epirubicin—prostate cancer	3.76e-05	0.000227	CcSEcCtD
Bupivacaine—Dyspepsia—Prednisone—prostate cancer	3.76e-05	0.000227	CcSEcCtD
Bupivacaine—Headache—Etoposide—prostate cancer	3.73e-05	0.000226	CcSEcCtD
Bupivacaine—Flatulence—Doxorubicin—prostate cancer	3.73e-05	0.000226	CcSEcCtD
Bupivacaine—Tension—Doxorubicin—prostate cancer	3.71e-05	0.000225	CcSEcCtD
Bupivacaine—Decreased appetite—Prednisone—prostate cancer	3.71e-05	0.000224	CcSEcCtD
Bupivacaine—Nervousness—Doxorubicin—prostate cancer	3.67e-05	0.000222	CcSEcCtD
Bupivacaine—Syncope—Epirubicin—prostate cancer	3.67e-05	0.000222	CcSEcCtD
Bupivacaine—Back pain—Doxorubicin—prostate cancer	3.66e-05	0.000221	CcSEcCtD
Bupivacaine—Constipation—Prednisone—prostate cancer	3.65e-05	0.000221	CcSEcCtD
Bupivacaine—Hypersensitivity—Docetaxel—prostate cancer	3.65e-05	0.000221	CcSEcCtD
Bupivacaine—Muscle spasms—Doxorubicin—prostate cancer	3.64e-05	0.00022	CcSEcCtD
Bupivacaine—Palpitations—Epirubicin—prostate cancer	3.61e-05	0.000219	CcSEcCtD
Bupivacaine—Loss of consciousness—Epirubicin—prostate cancer	3.59e-05	0.000217	CcSEcCtD
Bupivacaine—Cough—Epirubicin—prostate cancer	3.57e-05	0.000216	CcSEcCtD
Bupivacaine—Vision blurred—Doxorubicin—prostate cancer	3.57e-05	0.000216	CcSEcCtD
Bupivacaine—Asthenia—Docetaxel—prostate cancer	3.55e-05	0.000215	CcSEcCtD
Bupivacaine—Convulsion—Epirubicin—prostate cancer	3.54e-05	0.000214	CcSEcCtD
Bupivacaine—Nausea—Etoposide—prostate cancer	3.54e-05	0.000214	CcSEcCtD
Bupivacaine—Hypertension—Epirubicin—prostate cancer	3.53e-05	0.000214	CcSEcCtD
Bupivacaine—Hypersensitivity—Capecitabine—prostate cancer	3.53e-05	0.000214	CcSEcCtD
Bupivacaine—Feeling abnormal—Prednisone—prostate cancer	3.52e-05	0.000213	CcSEcCtD
Bupivacaine—Pruritus—Docetaxel—prostate cancer	3.5e-05	0.000212	CcSEcCtD
Bupivacaine—Anaemia—Doxorubicin—prostate cancer	3.5e-05	0.000212	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Prednisone—prostate cancer	3.49e-05	0.000211	CcSEcCtD
Bupivacaine—Arthralgia—Epirubicin—prostate cancer	3.48e-05	0.000211	CcSEcCtD
Bupivacaine—Agitation—Doxorubicin—prostate cancer	3.48e-05	0.00021	CcSEcCtD
Bupivacaine—Anxiety—Epirubicin—prostate cancer	3.47e-05	0.00021	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.46e-05	0.000209	CcSEcCtD
Bupivacaine—Asthenia—Capecitabine—prostate cancer	3.44e-05	0.000208	CcSEcCtD
Bupivacaine—Syncope—Doxorubicin—prostate cancer	3.39e-05	0.000205	CcSEcCtD
Bupivacaine—Urticaria—Prednisone—prostate cancer	3.39e-05	0.000205	CcSEcCtD
Bupivacaine—Pruritus—Capecitabine—prostate cancer	3.39e-05	0.000205	CcSEcCtD
Bupivacaine—Diarrhoea—Docetaxel—prostate cancer	3.39e-05	0.000205	CcSEcCtD
Bupivacaine—Abdominal pain—Prednisone—prostate cancer	3.37e-05	0.000204	CcSEcCtD
Bupivacaine—Body temperature increased—Prednisone—prostate cancer	3.37e-05	0.000204	CcSEcCtD
Bupivacaine—Confusional state—Epirubicin—prostate cancer	3.37e-05	0.000204	CcSEcCtD
Bupivacaine—Palpitations—Doxorubicin—prostate cancer	3.34e-05	0.000202	CcSEcCtD
Bupivacaine—Anaphylactic shock—Epirubicin—prostate cancer	3.34e-05	0.000202	CcSEcCtD
Bupivacaine—Oedema—Epirubicin—prostate cancer	3.34e-05	0.000202	CcSEcCtD
Bupivacaine—Loss of consciousness—Doxorubicin—prostate cancer	3.33e-05	0.000201	CcSEcCtD
Bupivacaine—Infection—Epirubicin—prostate cancer	3.32e-05	0.000201	CcSEcCtD
Bupivacaine—Cough—Doxorubicin—prostate cancer	3.3e-05	0.0002	CcSEcCtD
Bupivacaine—Shock—Epirubicin—prostate cancer	3.28e-05	0.000199	CcSEcCtD
Bupivacaine—Convulsion—Doxorubicin—prostate cancer	3.28e-05	0.000198	CcSEcCtD
Bupivacaine—Diarrhoea—Capecitabine—prostate cancer	3.28e-05	0.000198	CcSEcCtD
Bupivacaine—Nervous system disorder—Epirubicin—prostate cancer	3.27e-05	0.000198	CcSEcCtD
Bupivacaine—Dizziness—Docetaxel—prostate cancer	3.27e-05	0.000198	CcSEcCtD
Bupivacaine—Hypertension—Doxorubicin—prostate cancer	3.27e-05	0.000198	CcSEcCtD
Bupivacaine—Tachycardia—Epirubicin—prostate cancer	3.26e-05	0.000197	CcSEcCtD
Bupivacaine—Skin disorder—Epirubicin—prostate cancer	3.24e-05	0.000196	CcSEcCtD
Bupivacaine—Hyperhidrosis—Epirubicin—prostate cancer	3.23e-05	0.000195	CcSEcCtD
Bupivacaine—Arthralgia—Doxorubicin—prostate cancer	3.22e-05	0.000195	CcSEcCtD
Bupivacaine—Anxiety—Doxorubicin—prostate cancer	3.21e-05	0.000194	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.2e-05	0.000194	CcSEcCtD
Bupivacaine—Dizziness—Capecitabine—prostate cancer	3.17e-05	0.000192	CcSEcCtD
Bupivacaine—Vomiting—Docetaxel—prostate cancer	3.15e-05	0.00019	CcSEcCtD
Bupivacaine—Hypersensitivity—Prednisone—prostate cancer	3.14e-05	0.00019	CcSEcCtD
Bupivacaine—Hypotension—Epirubicin—prostate cancer	3.12e-05	0.000189	CcSEcCtD
Bupivacaine—Confusional state—Doxorubicin—prostate cancer	3.11e-05	0.000188	CcSEcCtD
Bupivacaine—Headache—Docetaxel—prostate cancer	3.1e-05	0.000188	CcSEcCtD
Bupivacaine—Anaphylactic shock—Doxorubicin—prostate cancer	3.09e-05	0.000187	CcSEcCtD
Bupivacaine—Oedema—Doxorubicin—prostate cancer	3.09e-05	0.000187	CcSEcCtD
Bupivacaine—Infection—Doxorubicin—prostate cancer	3.07e-05	0.000186	CcSEcCtD
Bupivacaine—Asthenia—Prednisone—prostate cancer	3.06e-05	0.000185	CcSEcCtD
Bupivacaine—Vomiting—Capecitabine—prostate cancer	3.05e-05	0.000184	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.04e-05	0.000184	CcSEcCtD
Bupivacaine—Shock—Doxorubicin—prostate cancer	3.04e-05	0.000184	CcSEcCtD
Bupivacaine—Nervous system disorder—Doxorubicin—prostate cancer	3.03e-05	0.000183	CcSEcCtD
Bupivacaine—Pruritus—Prednisone—prostate cancer	3.02e-05	0.000183	CcSEcCtD
Bupivacaine—Insomnia—Epirubicin—prostate cancer	3.02e-05	0.000183	CcSEcCtD
Bupivacaine—Tachycardia—Doxorubicin—prostate cancer	3.01e-05	0.000182	CcSEcCtD
Bupivacaine—Headache—Capecitabine—prostate cancer	3e-05	0.000182	CcSEcCtD
Bupivacaine—Skin disorder—Doxorubicin—prostate cancer	3e-05	0.000182	CcSEcCtD
Bupivacaine—Paraesthesia—Epirubicin—prostate cancer	3e-05	0.000181	CcSEcCtD
Bupivacaine—Hyperhidrosis—Doxorubicin—prostate cancer	2.99e-05	0.000181	CcSEcCtD
Bupivacaine—Dyspnoea—Epirubicin—prostate cancer	2.98e-05	0.00018	CcSEcCtD
Bupivacaine—Somnolence—Epirubicin—prostate cancer	2.97e-05	0.00018	CcSEcCtD
Bupivacaine—Nausea—Docetaxel—prostate cancer	2.94e-05	0.000178	CcSEcCtD
Bupivacaine—Dyspepsia—Epirubicin—prostate cancer	2.94e-05	0.000178	CcSEcCtD
Bupivacaine—Diarrhoea—Prednisone—prostate cancer	2.92e-05	0.000177	CcSEcCtD
Bupivacaine—Decreased appetite—Epirubicin—prostate cancer	2.9e-05	0.000176	CcSEcCtD
Bupivacaine—Hypotension—Doxorubicin—prostate cancer	2.89e-05	0.000175	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.88e-05	0.000174	CcSEcCtD
Bupivacaine—Constipation—Epirubicin—prostate cancer	2.85e-05	0.000173	CcSEcCtD
Bupivacaine—Pain—Epirubicin—prostate cancer	2.85e-05	0.000173	CcSEcCtD
Bupivacaine—Nausea—Capecitabine—prostate cancer	2.85e-05	0.000172	CcSEcCtD
Bupivacaine—Dizziness—Prednisone—prostate cancer	2.82e-05	0.000171	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.81e-05	0.00017	CcSEcCtD
Bupivacaine—Insomnia—Doxorubicin—prostate cancer	2.79e-05	0.000169	CcSEcCtD
Bupivacaine—Paraesthesia—Doxorubicin—prostate cancer	2.77e-05	0.000168	CcSEcCtD
Bupivacaine—Dyspnoea—Doxorubicin—prostate cancer	2.75e-05	0.000167	CcSEcCtD
Bupivacaine—Feeling abnormal—Epirubicin—prostate cancer	2.75e-05	0.000166	CcSEcCtD
Bupivacaine—Somnolence—Doxorubicin—prostate cancer	2.75e-05	0.000166	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Epirubicin—prostate cancer	2.73e-05	0.000165	CcSEcCtD
Bupivacaine—Dyspepsia—Doxorubicin—prostate cancer	2.72e-05	0.000164	CcSEcCtD
Bupivacaine—Vomiting—Prednisone—prostate cancer	2.71e-05	0.000164	CcSEcCtD
Bupivacaine—Decreased appetite—Doxorubicin—prostate cancer	2.68e-05	0.000162	CcSEcCtD
Bupivacaine—Headache—Prednisone—prostate cancer	2.67e-05	0.000162	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.67e-05	0.000161	CcSEcCtD
Bupivacaine—Urticaria—Epirubicin—prostate cancer	2.65e-05	0.00016	CcSEcCtD
Bupivacaine—Pain—Doxorubicin—prostate cancer	2.64e-05	0.00016	CcSEcCtD
Bupivacaine—Constipation—Doxorubicin—prostate cancer	2.64e-05	0.00016	CcSEcCtD
Bupivacaine—Abdominal pain—Epirubicin—prostate cancer	2.64e-05	0.00016	CcSEcCtD
Bupivacaine—Body temperature increased—Epirubicin—prostate cancer	2.64e-05	0.00016	CcSEcCtD
Bupivacaine—Feeling abnormal—Doxorubicin—prostate cancer	2.54e-05	0.000154	CcSEcCtD
Bupivacaine—Nausea—Prednisone—prostate cancer	2.53e-05	0.000153	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.53e-05	0.000153	CcSEcCtD
Bupivacaine—Hypersensitivity—Epirubicin—prostate cancer	2.46e-05	0.000149	CcSEcCtD
Bupivacaine—Urticaria—Doxorubicin—prostate cancer	2.45e-05	0.000148	CcSEcCtD
Bupivacaine—Body temperature increased—Doxorubicin—prostate cancer	2.44e-05	0.000148	CcSEcCtD
Bupivacaine—Abdominal pain—Doxorubicin—prostate cancer	2.44e-05	0.000148	CcSEcCtD
Bupivacaine—Asthenia—Epirubicin—prostate cancer	2.39e-05	0.000145	CcSEcCtD
Bupivacaine—Pruritus—Epirubicin—prostate cancer	2.36e-05	0.000143	CcSEcCtD
Bupivacaine—Diarrhoea—Epirubicin—prostate cancer	2.28e-05	0.000138	CcSEcCtD
Bupivacaine—Hypersensitivity—Doxorubicin—prostate cancer	2.28e-05	0.000138	CcSEcCtD
Bupivacaine—Asthenia—Doxorubicin—prostate cancer	2.22e-05	0.000134	CcSEcCtD
Bupivacaine—Dizziness—Epirubicin—prostate cancer	2.21e-05	0.000134	CcSEcCtD
Bupivacaine—Pruritus—Doxorubicin—prostate cancer	2.18e-05	0.000132	CcSEcCtD
Bupivacaine—Vomiting—Epirubicin—prostate cancer	2.12e-05	0.000128	CcSEcCtD
Bupivacaine—Diarrhoea—Doxorubicin—prostate cancer	2.11e-05	0.000128	CcSEcCtD
Bupivacaine—Headache—Epirubicin—prostate cancer	2.09e-05	0.000127	CcSEcCtD
Bupivacaine—Dizziness—Doxorubicin—prostate cancer	2.04e-05	0.000124	CcSEcCtD
Bupivacaine—Nausea—Epirubicin—prostate cancer	1.98e-05	0.00012	CcSEcCtD
Bupivacaine—Vomiting—Doxorubicin—prostate cancer	1.96e-05	0.000119	CcSEcCtD
Bupivacaine—Headache—Doxorubicin—prostate cancer	1.93e-05	0.000117	CcSEcCtD
Bupivacaine—Nausea—Doxorubicin—prostate cancer	1.83e-05	0.000111	CcSEcCtD
Bupivacaine—CYP1A2—Metabolism—GSTA4—prostate cancer	5.96e-06	6.4e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TBXAS1—prostate cancer	5.96e-06	6.4e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOA3—prostate cancer	5.96e-06	6.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.91e-06	6.35e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.91e-06	6.35e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.86e-06	6.29e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SULT2A1—prostate cancer	5.83e-06	6.26e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.83e-06	6.25e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AKT1—prostate cancer	5.82e-06	6.25e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTA2—prostate cancer	5.81e-06	6.24e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SULT1A1—prostate cancer	5.74e-06	6.16e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCG5—prostate cancer	5.74e-06	6.16e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MED12—prostate cancer	5.74e-06	6.16e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GNG5—prostate cancer	5.69e-06	6.11e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EP300—prostate cancer	5.69e-06	6.11e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HPGDS—prostate cancer	5.69e-06	6.1e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ACSL4—prostate cancer	5.64e-06	6.06e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.64e-06	6.06e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTA1—prostate cancer	5.6e-06	6.02e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HSD3B2—prostate cancer	5.54e-06	5.95e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTO1—prostate cancer	5.54e-06	5.95e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NAT2—prostate cancer	5.54e-06	5.95e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SRC—prostate cancer	5.53e-06	5.94e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ACHE—prostate cancer	5.51e-06	5.92e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTT1—prostate cancer	5.51e-06	5.92e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOA3—prostate cancer	5.48e-06	5.88e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP2A6—prostate cancer	5.45e-06	5.85e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.43e-06	5.83e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PHGDH—prostate cancer	5.41e-06	5.81e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ARG2—prostate cancer	5.41e-06	5.81e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—UMPS—prostate cancer	5.41e-06	5.81e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—prostate cancer	5.39e-06	5.78e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STAT3—prostate cancer	5.33e-06	5.73e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.33e-06	5.72e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2C18—prostate cancer	5.31e-06	5.7e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LRP2—prostate cancer	5.31e-06	5.7e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLCB2—prostate cancer	5.31e-06	5.7e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LDHB—prostate cancer	5.31e-06	5.7e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKR1C3—prostate cancer	5.3e-06	5.69e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PRKACB—prostate cancer	5.27e-06	5.66e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HPGDS—prostate cancer	5.23e-06	5.61e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP17A1—prostate cancer	5.22e-06	5.6e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—P4HB—prostate cancer	5.21e-06	5.59e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.21e-06	5.59e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2C19—prostate cancer	5.2e-06	5.58e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.15e-06	5.53e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ACHE—prostate cancer	5.07e-06	5.44e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTT1—prostate cancer	5.07e-06	5.44e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC22A1—prostate cancer	5.07e-06	5.44e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PDHA1—prostate cancer	5.03e-06	5.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA3—prostate cancer	5.03e-06	5.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—UCP3—prostate cancer	5.03e-06	5.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TCN2—prostate cancer	5.03e-06	5.4e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.01e-06	5.38e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.01e-06	5.38e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOA2—prostate cancer	4.97e-06	5.34e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—prostate cancer	4.96e-06	5.32e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—prostate cancer	4.94e-06	5.31e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SULT2A1—prostate cancer	4.94e-06	5.3e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKR1C3—prostate cancer	4.88e-06	5.24e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MED12—prostate cancer	4.86e-06	5.22e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PRKACB—prostate cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGFR—prostate cancer	4.85e-06	5.2e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GNG5—prostate cancer	4.82e-06	5.17e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP17A1—prostate cancer	4.8e-06	5.15e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.8e-06	5.15e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.8e-06	5.15e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.74e-06	5.09e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOA3—prostate cancer	4.64e-06	4.98e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.63e-06	4.98e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA4—prostate cancer	4.6e-06	4.94e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.6e-06	4.94e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NQO1—prostate cancer	4.58e-06	4.92e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KRAS—prostate cancer	4.58e-06	4.92e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOA2—prostate cancer	4.57e-06	4.91e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.56e-06	4.9e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TH—prostate cancer	4.52e-06	4.85e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.49e-06	4.82e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA2—prostate cancer	4.48e-06	4.81e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP3A4—prostate cancer	4.47e-06	4.8e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.45e-06	4.77e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HPGDS—prostate cancer	4.43e-06	4.76e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCG5—prostate cancer	4.43e-06	4.75e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.43e-06	4.75e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2C19—prostate cancer	4.4e-06	4.73e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP1B1—prostate cancer	4.39e-06	4.72e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.36e-06	4.69e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA1—prostate cancer	4.32e-06	4.64e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTT1—prostate cancer	4.3e-06	4.61e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ACHE—prostate cancer	4.3e-06	4.61e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTO1—prostate cancer	4.28e-06	4.59e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.28e-06	4.59e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NAT2—prostate cancer	4.28e-06	4.59e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.26e-06	4.58e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GGT1—prostate cancer	4.25e-06	4.57e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2A6—prostate cancer	4.25e-06	4.56e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.23e-06	4.54e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NQO1—prostate cancer	4.21e-06	4.52e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CA—prostate cancer	4.21e-06	4.52e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOA1—prostate cancer	4.19e-06	4.5e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TH—prostate cancer	4.15e-06	4.46e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.13e-06	4.44e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.13e-06	4.43e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.11e-06	4.41e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PRKACB—prostate cancer	4.11e-06	4.41e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.1e-06	4.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLCB2—prostate cancer	4.1e-06	4.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LRP2—prostate cancer	4.1e-06	4.4e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—prostate cancer	4.07e-06	4.37e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.07e-06	4.37e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.04e-06	4.34e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—P4HB—prostate cancer	4.02e-06	4.32e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.01e-06	4.31e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—RXRA—prostate cancer	3.99e-06	4.28e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GGT1—prostate cancer	3.91e-06	4.2e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.91e-06	4.2e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.88e-06	4.16e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOA2—prostate cancer	3.88e-06	4.16e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOA1—prostate cancer	3.85e-06	4.14e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—COMT—prostate cancer	3.84e-06	4.12e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTP1—prostate cancer	3.82e-06	4.1e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.81e-06	4.09e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.8e-06	4.08e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ITPR1—prostate cancer	3.76e-06	4.04e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MED12—prostate cancer	3.75e-06	4.03e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—prostate cancer	3.73e-06	4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GNG5—prostate cancer	3.72e-06	3.99e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.7e-06	3.97e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.7e-06	3.97e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—RXRA—prostate cancer	3.67e-06	3.94e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.61e-06	3.88e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOA3—prostate cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NQO1—prostate cancer	3.57e-06	3.83e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TYMS—prostate cancer	3.55e-06	3.81e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—COMT—prostate cancer	3.53e-06	3.79e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TH—prostate cancer	3.52e-06	3.78e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTP1—prostate cancer	3.52e-06	3.77e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTM1—prostate cancer	3.51e-06	3.77e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.5e-06	3.75e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.48e-06	3.74e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.46e-06	3.72e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ITPR1—prostate cancer	3.46e-06	3.71e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LPL—prostate cancer	3.45e-06	3.7e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKT1—prostate cancer	3.44e-06	3.69e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.42e-06	3.68e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HPGDS—prostate cancer	3.42e-06	3.67e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.4e-06	3.65e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.33e-06	3.57e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTT1—prostate cancer	3.32e-06	3.56e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ACHE—prostate cancer	3.32e-06	3.56e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GGT1—prostate cancer	3.32e-06	3.56e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ERCC2—prostate cancer	3.3e-06	3.55e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.28e-06	3.52e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TYMS—prostate cancer	3.27e-06	3.51e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOA1—prostate cancer	3.27e-06	3.51e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTM1—prostate cancer	3.23e-06	3.47e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.22e-06	3.46e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.19e-06	3.42e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.17e-06	3.4e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LPL—prostate cancer	3.17e-06	3.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.14e-06	3.37e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—RXRA—prostate cancer	3.11e-06	3.33e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—prostate cancer	3.1e-06	3.33e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.06e-06	3.29e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARA—prostate cancer	3.05e-06	3.27e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ERCC2—prostate cancer	3.04e-06	3.26e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.02e-06	3.24e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—COMT—prostate cancer	2.99e-06	3.21e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.99e-06	3.21e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTP1—prostate cancer	2.98e-06	3.2e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ITPR1—prostate cancer	2.93e-06	3.15e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.88e-06	3.09e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CAV1—prostate cancer	2.86e-06	3.07e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.85e-06	3.06e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.85e-06	3.06e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARA—prostate cancer	2.8e-06	3.01e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.79e-06	2.99e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TYMS—prostate cancer	2.77e-06	2.97e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NQO1—prostate cancer	2.76e-06	2.96e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTM1—prostate cancer	2.74e-06	2.94e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.74e-06	2.94e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TH—prostate cancer	2.72e-06	2.92e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LPL—prostate cancer	2.69e-06	2.88e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.64e-06	2.84e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CAV1—prostate cancer	2.63e-06	2.83e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.61e-06	2.8e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.59e-06	2.79e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ERCC2—prostate cancer	2.57e-06	2.76e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GGT1—prostate cancer	2.56e-06	2.75e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.52e-06	2.71e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—INS—prostate cancer	2.47e-06	2.65e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—prostate cancer	2.42e-06	2.6e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CREBBP—prostate cancer	2.42e-06	2.6e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.4e-06	2.58e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—RXRA—prostate cancer	2.4e-06	2.57e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARA—prostate cancer	2.37e-06	2.55e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—COMT—prostate cancer	2.31e-06	2.48e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.3e-06	2.47e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.29e-06	2.46e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—INS—prostate cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.26e-06	2.43e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CAV1—prostate cancer	2.23e-06	2.4e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.22e-06	2.39e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NOS3—prostate cancer	2.16e-06	2.32e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TYMS—prostate cancer	2.14e-06	2.29e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.13e-06	2.29e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.11e-06	2.27e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.11e-06	2.26e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LPL—prostate cancer	2.07e-06	2.23e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.03e-06	2.18e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2e-06	2.15e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CB—prostate cancer	2e-06	2.15e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NOS3—prostate cancer	1.99e-06	2.14e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.98e-06	2.13e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—INS—prostate cancer	1.92e-06	2.07e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.88e-06	2.02e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.87e-06	2e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.84e-06	1.97e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARA—prostate cancer	1.83e-06	1.97e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.82e-06	1.96e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.79e-06	1.92e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTEN—prostate cancer	1.73e-06	1.85e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CAV1—prostate cancer	1.72e-06	1.85e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NOS3—prostate cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—EP300—prostate cancer	1.65e-06	1.77e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTEN—prostate cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.57e-06	1.68e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.56e-06	1.67e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.54e-06	1.66e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—EP300—prostate cancer	1.51e-06	1.63e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—INS—prostate cancer	1.48e-06	1.59e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.45e-06	1.56e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTEN—prostate cancer	1.35e-06	1.44e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NOS3—prostate cancer	1.3e-06	1.4e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—EP300—prostate cancer	1.28e-06	1.38e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.31e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.2e-06	1.29e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.19e-06	1.28e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.12e-06	1.2e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTEN—prostate cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKT1—prostate cancer	9.95e-07	1.07e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—EP300—prostate cancer	9.9e-07	1.06e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CA—prostate cancer	9.49e-07	1.02e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKT1—prostate cancer	9.15e-07	9.83e-06	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKT1—prostate cancer	7.75e-07	8.32e-06	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.33e-07	7.86e-06	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKT1—prostate cancer	5.98e-07	6.42e-06	CbGpPWpGaD
